EUVIMEDEUVIMED entdecken
Crossref

139 Efficacy and Safety of a Topical inflammasome inhibitor targeting GPCR19 Agonist in Mild-to-Moderate Atopic Dermatitis: Results from Phase 2 Studies

Seung-Yong Seong, Gyeong Ho Baek, Soojin Jun, Vlada Groysman, Jung-Im Na

Journal of Investigative Dermatology · 2025-11 · 145 (11) · e54

DOI: 10.1016/j.jid.2025.09.154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Seung-Yong Seong und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Seong, S., Baek, G. H., Jun, S., Groysman, V., & Na, J. (2025). 139 Efficacy and Safety of a Topical inflammasome inhibitor targeting GPCR19 Agonist in Mild-to-Moderate Atopic Dermatitis: Results from Phase 2 Studies. Journal of Investigative Dermatology, 145(11), e54. https://doi.org/10.1016/j.jid.2025.09.154

Vancouver

Seong S, Baek GH, Jun S, Groysman V, Na J. 139 Efficacy and Safety of a Topical inflammasome inhibitor targeting GPCR19 Agonist in Mild-to-Moderate Atopic Dermatitis: Results from Phase 2 Studies. Journal of Investigative Dermatology. 2025;145(11):e54. doi:10.1016/j.jid.2025.09.154

BibTeX
@article{Seong2025,
  author = {Seong, Seung-Yong and Baek, Gyeong Ho and Jun, Soojin and Groysman, Vlada and Na, Jung-Im},
  title = {139 Efficacy and Safety of a Topical inflammasome inhibitor targeting GPCR19 Agonist in Mild-to-Moderate Atopic Dermatitis: Results from Phase 2 Studies},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {11},
  pages = {e54},
  doi = {10.1016/j.jid.2025.09.154}
}
Kostenlos starten →